Loading...
Market
What will be SpectraWAVE's valuation by end of Q1 2025?
3
Resolution / Starting Odds
Less than $200M • 25%
$200M to $300M • 25%
$300M to $400M • 25%
More than $400M • 25%
Official financial statements or news reports on SpectraWAVE's valuation
Story
SpectraWAVE Secures $50M Series B Led by Johnson & Johnson for HyperVue™ Expansion
Sep 11, 2024, 01:02 PM
SpectraWAVE has announced a $50 million Series B financing round aimed at driving commercial expansion and product additions to its HyperVue™ Imaging System. The funding round is led by Johnson & Johnson, with participation from Lumira Ventures, Deerfield Management, SV Health Investors, and S3 Ventures. CEO Eman Namati stated that this financing is expected to significantly enhance SpectraWAVE's capabilities in improving treatment and outcomes for patients with coronary artery disease.
View original story
Similar markets
Less than $300 million • 25%
$300 million to $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $400M • 25%
$400M to $499M • 25%
$500M to $599M • 25%
$600M or more • 25%
Below $30 billion • 25%
$30 billion to $35 billion • 25%
$35 billion to $40 billion • 25%
Above $40 billion • 25%
Less than $23 billion • 25%
$23 billion to $25 billion • 25%
$25 billion to $27 billion • 25%
More than $27 billion • 25%
Less than $20 billion • 25%
$20 billion to $25 billion • 25%
$25 billion to $30 billion • 25%
More than $30 billion • 25%
$23B to $30B • 25%
$30B to $35B • 25%
$35B to $40B • 25%
Over $40B • 25%
Under $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
Over $10 billion • 25%
Less than $1B • 25%
$1B to $2B • 25%
$2B to $3B • 25%
More than $3B • 25%